In partnership with Eli Lilly and Company, the Suits alum is now raising awareness about early symptomatic Alzheimer's ...

A gene variant called APOE4 is the biggest genetic risk factor for Alzheimer's disease. Scientists are finally figuring out ...

A particular gene variant called APOE ε4 is considered a high-risk factor for developing Alzheimer’s disease — so strong that ...

Researchers developed a drug for Alzheimer's disease and then discovered that the molecule already exists in human blood and ...

PRI analysis shows Alzheimer’s biomarkers like Amyloid PET and plasma p-tau217 are driving earlier, precise diagnosis and staging.

Patients with early-onset Alzheimer's disease have a distinct comorbidity profile and increased healthcare use in the years before diagnosis, a study shows.

Learn how Alzheimer's disease is diagnosed through history, testing, imaging, and emerging blood biomarkers to support early ...

After decades of research, US scientists may finally be closing in on new ways to fight Alzheimer’s. But even the most ...

Dementia and Alzheimer’s disease are closely related, but the terms describe different things. Dementia is a pattern of problems with memory, thinking or behaviour that interferes with daily life, ...

Alzheimer's disease is best known for its effects on memory and cognition, but the disease also involves changes in how brain ...

Shanghai Fosun Pharmaceuticals secured regional rights to AR1001 via a $60M option fee. Find out why SFOSF stock is a hold.

Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer will enable GMP manufacture of clinical trial ...